2023
Exports
$183MWorld Rnk 21 / 190
Flag Rnk 263 / 1188
2023
PRODUCT COMPLEXITY IN Special Pharmaceuticals
0.53Rnk 356 / 1025
2023
Imports
$275MWorld Rnk 15 / 220
Flag Rnk 250 / 1208
2023
ECONOMIC COMPLEXITY of South Korea
1.85Rnk 4 / 132

About

Exports In 2023, South Korea exported $183M in Special Pharmaceuticals, making it the 21st largest exporter of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 263rd most exported product in South Korea. The main destination of Special Pharmaceuticals exports from South Korea are: Japan ($29.8M), United States ($17.8M), China ($14.6M), Brazil ($13.7M), and Turkey ($6.22M).

The fastest growing export markets for Special Pharmaceuticals of South Korea between 2022 and 2023 were Japan ($5.7M), United States ($2.44M), and Guatemala ($1.34M).

Imports In 2023, South Korea imported $275M in Special Pharmaceuticals, becoming the 15th largest importer of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 250th most imported product in South Korea. South Korea imports Special Pharmaceuticals primarily from: United States ($62.1M), Germany ($56.8M), China ($22.7M), Italy ($21.7M), and France ($18.3M).

The fastest growing import markets in Special Pharmaceuticals for South Korea between 2022 and 2023 were Germany ($14.9M), Singapore ($11.1M), and United States ($9.34M).

COMPANIES In 2024, leading companies such as Sumitomo Rubber (4) and LG Electronics (2) were at the forefront of shipping Special Pharmaceuticals from South Korea to the United States.

Latest Trends

January 2025

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (January 2024 - January 2025)$-3.15M(-17.6%)
IMPORT GROWTH (January 2024 - January 2025)$-2.33M(-8.58%)
MAIN DESTINATION (January 2025)Japan$2.39M

This section shows Special Pharmaceuticals's exports and imports data at subnational level for South Korea. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Special Pharmaceuticals over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$183M
IMPORTS (2023)$275M
NET TRADE (2023)-$92.5M

In 2023, South Korea exported $183M in Special Pharmaceuticals. The main destinations of South Korea exports on Special Pharmaceuticals were Japan ($29.8M), United States ($17.8M), China ($14.6M), Brazil ($13.7M), and Turkey ($6.22M).

In 2023, South Korea imported $275M in Special Pharmaceuticals, mainly from United States ($62.1M), Germany ($56.8M), China ($22.7M), Italy ($21.7M), and France ($18.3M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Special Pharmaceuticals EXPORT MARKETS FOR South Korea WERE (2022 - 2023):
Japan$5.7M (23.6%)
United States$2.44M (15.8%)
Guatemala$1.34M (68.4%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Special Pharmaceuticals BY South Korea WERE (2022 - 2023):
Saudi Arabia-$30.3M (-85.9%)
Russia-$12.1M (-100%)
Vietnam-$7.65M (-100%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, South Korea's main exporting competitors in Special Pharmaceuticals were:
In 2023, South Korea's main importing competitors in Special Pharmaceuticals were:

Explore Visualizations

Trade Value of Special Pharmaceuticals by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALChina+ $14.1M
TOP IMPORT POTENTIALChina+ $12M

Special Pharmaceuticals’s highest export potential is China. With an export gap of $14.1M.   Special Pharmaceuticals’s highest import potential is China with an import gap of $12M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with